Finance

Beta
Ask
Lists
000020:KRX
Dongwha Pharm Co Ltd
₩5,330.00
+0.38%
(+20.00) 1D
Jun 12, 3:30:03 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000020...
Open
₩5,360
High
₩5,470
Low
₩5,330
Mkt. cap
148.87B
Avg. vol.
120.38K
Volume
0.00
Dividend
1.22%
Quarterly dividend
₩16
Ex-dividend date
Dec 27, 2024
P/E ratio
7.91
52-wk high
₩7,140
52-wk low
₩5,150
EPS
₩674
Shares outstanding
27.93M
No. of employees
826
Open
₩5,360
High
₩5,470
Low
₩5,330
Mkt. cap
148.87B
Avg. vol.
120.38K
Volume
0.00
Dividend
1.22%
Quarterly dividend
₩16
Ex-dividend date
Dec 27, 2024
P/E ratio
7.91
52-wk high
₩7,140
52-wk low
₩5,150
EPS
₩674
Shares outstanding
27.93M
No. of employees
826
News stories
From sources across the web
About Dongwha Pharm Co Ltd
CEOYoo Jun-ha | Han Jong-hyun
Employees826
FoundedSep 25, 1897
Headquarters-
SectorPharmaceutical industry
Websitedong-wha.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
125.02B
122.00B
123.70B
130.61B
Cost of goods sold
68.53B
67.03B
71.57B
70.80B
Cost of revenue
68.53B
67.03B
71.57B
70.80B
Research and development expenses
-2.25B
1.73B
20.32B
5.42B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.26B
47.10B
33.31B
39.80B
Operating expense
55.89B
53.60B
56.63B
48.58B
Total operating expenses
124.41B
120.63B
128.19B
119.39B
Operating income
614.12M
1.37B
-4.50B
11.23B
Other non operating income
-1.45B
641.83M
-65.61M
892.29M
EBT including unusual items
9.34B
875.23M
-4.88B
8.07B
EBT excluding unusual items
-1.24B
1.52B
-5.68B
10.74B
Income tax expense
3.21B
633.61M
-3.15B
-1.58B
Effective tax rate
34.35%
72.39%
64.47%
-19.64%
Other operating expenses
1.07B
628.08M
154.48M
510.81M
Net income
7.24B
957.13M
454.02M
10.02B
Net profit margin
5.79%
0.78%
0.37%
7.67%
Earnings per share
-
-
-
-
Interest and investment income
225.94M
1.10B
382.40M
272.32M
Interest expense
-816.35M
-1.30B
-1.47B
-1.42B
Net interest expenses
-590.40M
-206.66M
-1.09B
-1.14B
Depreciation and amortization charges
3.32B
2.95B
1.09B
2.23B
EBITDA
5.86B
7.02B
1.28B
16.74B
Gain or loss from assets sale
-9.02B
-2.36M
11.97M
-18.54M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer